The Pharmacy Council of Pakistan (PCP) has instituted major regulatory action across the country, barring 14 universities and colleges from admitting students to their Doctor of Pharmacy (Pharm-D) programmes and issuing formal show-cause notices to 29 other institutions. The widespread disciplinary measures bring the total number of institutions facing council scrutiny to 43, signaling critical compliance warnings for prospective students and parents during the ongoing admission cycle.
According to the official document, titled '14 Institutions Stopped From Pharm-D Admissions', the council enforced an immediate ban on new intakes at notable institutions, including the University of Health Sciences (UHS) in Lahore, Iqra University's Islamabad campus, and Abasyn University. The regulatory sanctions stem from non-compliance with statutory academic benchmarks, teaching faculty ratios, and physical infrastructure requirements.
PCP Regulatory Enforcement Summary
| Action Type | Total Institutions | Provincial Breakdown | Prominent Institutions Named |
|---|---|---|---|
| Admissions Barred | 14 | Islamabad (7), Punjab (6), Khyber Pakhtunkhwa (1) | University of Health Sciences (Lahore), Iqra University (Islamabad), Abasyn University |
| Show-Cause Notices | 29 | Punjab (22), Khyber Pakhtunkhwa (4), Sindh (3) | University of Sindh, Shaheed Benazir Bhutto Dewan University, Bharghari Institute of Pharmacy, Bahauddin Zakariya University, Nishtar Medical University |
Provincial Distribution and Institutional Deficiencies
The regulatory lists released by the council demonstrate that Punjab faces the largest volume of scrutiny, comprising 6 barred institutions and 22 under show-cause notices. Islamabad accounts for 7 barred institutions, while Khyber Pakhtunkhwa has 1 barred institution and 4 facing notices. In Sindh, three institutions received show-cause notices, prompting heightened scrutiny of regional academic standards.
The PCP noted specific infrastructure and staffing violations among the institutions under review. The council raised serious objections regarding the University of Sindh, where the designated pharmacy building was found to concurrently house the Department of Eastern Medicine and Surgery. At Shaheed Benazir Bhutto Dewan University in Karachi, inspections revealed that pharmacy laboratories were undersized and that unrelated academic programmes were operating within the building earmarked specifically for Pharm-D instruction. The council further highlighted the absence of an independent pharmacy library and computer laboratory at the facility. Meanwhile, at the Bharghari Institute of Pharmacy in Matli, Badin district, the council expressed a lack of confidence in the faculty and ordered the administration to recruit qualified, professionally competent teachers without delay.
Direct Impact on Pakistani Students and Parents
The council's enforcement has immediate consequences for applicants and their families. Enrolling in a Pharm-D programme at a barred or unaccredited institution jeopardizes degree legitimacy. Under statutory rules, graduates from non-compliant programmes are not eligible for professional registration with the Pharmacy Council of Pakistan, leaving them disqualified from obtaining a practicing pharmacy license or securing official clinical and industrial appointments.
Parents and students are strongly urged to cross-verify the accreditation and regulatory status of any prospective university directly with the PCP before submitting admission fees or confirming seat allotments. For institutions currently under show-cause notices—including Nishtar Medical University and Bahauddin Zakariya University—applicants should actively monitor whether administrative rectifications satisfy council standards before committing to enrollment.
Source: Originally reported by Pakistani Universities.
Source: Originally reported by Pakistani Universities.
Source: ProPakistani